|
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 36780194 | ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma. | Clin Cancer Res | 2023 |
| 37494625 | Anti-SARS-CoV-2 Monoclonal Antibodies in Pediatrics: Statewide Experience in Rhode Island. | R I Med J (2013) | 2023 |
| 37492101 | OpenPBTA: The Open Pediatric Brain Tumor Atlas. | Cell Genom | 2023 |
| 37494625 | Anti-SARS-CoV-2 Monoclonal Antibodies in Pediatrics: Statewide Experience in Rhode Island. | R I Med J (2013) | 2023 |
| 37492101 | OpenPBTA: The Open Pediatric Brain Tumor Atlas. | Cell Genom | 2023 |
| 36780194 | ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma. | Clin Cancer Res | 2023 |
| 36279962 | Comparative flow cytometry-based immunophenotyping analysis of peripheral blood leukocytes before and after fixation with paraformaldehyde. | J Immunol Methods | 2022 |
| 35703183 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2022 |
| 36279962 | Comparative flow cytometry-based immunophenotyping analysis of peripheral blood leukocytes before and after fixation with paraformaldehyde. | J Immunol Methods | 2022 |
| 35703183 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2022 |
| 34246076 | EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG. | Neoplasia | 2021 |
| 33658570 | Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. | Sci Rep | 2021 |
| 34246076 | EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG. | Neoplasia | 2021 |
| 34965294 | Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma. | J Neuropathol Exp Neurol | 2021 |
| 34659909 | Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosis. | Am J Cancer Res | 2021 |
| 33658570 | Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. | Sci Rep | 2021 |
| 34965294 | Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma. | J Neuropathol Exp Neurol | 2021 |
| 34659909 | Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosis. | Am J Cancer Res | 2021 |
| 31613963 | Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. | Neuro Oncol | 2020 |
| 31613963 | Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. | Neuro Oncol | 2020 |
| 32817593 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2020 |
| 32817593 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2020 |
| 30670636 | Transcriptional repressor REST drives lineage stage-specific chromatin compaction at <i>Ptch1</i> and increases AKT activation in a mouse model of medulloblastoma. | Sci Signal | 2019 |
| 31227500 | Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma. | Clin Cancer Res | 2019 |
| 30670636 | Transcriptional repressor REST drives lineage stage-specific chromatin compaction at <i>Ptch1</i> and increases AKT activation in a mouse model of medulloblastoma. | Sci Signal | 2019 |
| 31105875 | Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. | Oncotarget | 2019 |
| 30997512 | Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients. | Neuro Oncol | 2019 |
| 31227500 | Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma. | Clin Cancer Res | 2019 |
| 30997512 | Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients. | Neuro Oncol | 2019 |
| 31105875 | Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. | Oncotarget | 2019 |
| 29401100 | Primary Central Nervous System Malignant Melanoma in Children: A Case Series and Review of the Literature. | J Pediatr Hematol Oncol | 2018 |
| 30647848 | Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. | Oncotarget | 2018 |
| 29401100 | Primary Central Nervous System Malignant Melanoma in Children: A Case Series and Review of the Literature. | J Pediatr Hematol Oncol | 2018 |
| 30647848 | Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. | Oncotarget | 2018 |
| 28860053 | Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors. | Transl Res | 2017 |
| 28860053 | Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors. | Transl Res | 2017 |
| 28416018 | Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. | Acta Neuropathol Commun | 2017 |
| 28523881 | Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib. | Pediatr Dermatol | 2017 |
| 29435175 | REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature. | Oncotarget | 2017 |
| 28263307 | Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. | Nat Med | 2017 |
| 28416018 | Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. | Acta Neuropathol Commun | 2017 |
| 28263307 | Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. | Nat Med | 2017 |
| 29435175 | REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature. | Oncotarget | 2017 |
| 28523881 | Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib. | Pediatr Dermatol | 2017 |
| 27022131 | Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study. | Neuro Oncol | 2016 |
| 27022131 | Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study. | Neuro Oncol | 2016 |
| 27370397 | Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. | Neuro Oncol | 2016 |
| 27120806 | Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition. | Oncotarget | 2016 |